IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts15151515
Avg. Estimate-0.76-0.5-2.26-1.53
Low estimate-1.72-0.58-3.16-2.05
High estimate-0.41-0.41-1.73-0.71
Year ago EPS-0.63-0.63-2.49-2.26
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts14141414
Avg. Estimate3.07M5.59M22.12M170.83M
Low estimateN/AN/AN/A33.2M
High estimate21M22M74.93M429.66M
Year ago salesN/AN/AN/A22.12M
Sales growth (year/est)N/AN/AN/A672.30%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.61-0.64-0.64-0.74
Actual EPS-0.63-0.63-0.64-0.5
Difference-0.020.0100.24
Surprise %-3.30%1.60%0.00%32.40%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.76-0.5-2.26-1.53
7 days ago-0.76-0.5-2.25-1.54
30 days ago-0.64-0.55-2.45-1.62
60 days ago-0.64-0.55-2.45-1.62
90 days ago-0.66-0.57-2.5-1.66
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 days21N/A3
Up last 30 days61049
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A3N/A
Growth estimatesIOVAIndustrySector(s)S&P 500
Current qtr.-20.60%N/AN/AN/A
Next qtr.20.60%N/AN/AN/A
Current year9.20%N/AN/AN/A
Next year32.30%N/AN/AN/A
Next 5 years (per annum)-19.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A